Begelomab (Anti-DPP4 / CD26)
Begelomab (Anti-DPP4 / CD26) is a monoclonal antibody targeting DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy. MW: 145.5 KD.
| Trivial name | SAND-26 |
| Catalog Number | A2517 |
| CAS# | 1403744-56-8 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/begelomab-anti-dpp4-cd26.html |